These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


358 related items for PubMed ID: 1770632

  • 1. [Intraglomerular coagulation and fibrinolysis in human primary glomerular diseases].
    Shibata K, Dohi K, Fujii Y, Ishikawa H.
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):719-29. PubMed ID: 1770632
    [Abstract] [Full Text] [Related]

  • 2. Clinical significance of urinary fibrin/fibrinogen degradation products (FDP) as measured by latex photometric immunoassay in renal diseases.
    Kaizu K, Ito Y, Uriu K, Eto S.
    Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):29-34. PubMed ID: 8336397
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Significance of urinary fibrin/fibrinogen degradation products (FDP) measured by highly sensitive ELISA method in various renal diseases].
    Shibata T, Sumie A, Ishii T, Tomo T, Magari Y, Sato J, Yasumori R, Nasu M.
    Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):687-94. PubMed ID: 8377281
    [Abstract] [Full Text] [Related]

  • 7. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
    Rość D, Kremplewska-Nalezyta E, Gadomska G, Zastawna E, Michalski A, Drewniak W.
    Med Sci Monit; 2000 Jun; 6(4):684-91. PubMed ID: 11208392
    [Abstract] [Full Text] [Related]

  • 8. [An experimental study of local fibrinolysis using tissue plasminogen activator and urokinase in a canine common carotid artery thrombus model].
    Kawakami K, Takahashi A, Yoshimoto T.
    No To Shinkei; 1990 Feb; 42(2):193-201. PubMed ID: 2113401
    [Abstract] [Full Text] [Related]

  • 9. Fibrinolysis system in patients with bronchial asthma.
    Banach-Wawrzeńczyk E, Dziedziczko A, Rość D.
    Med Sci Monit; 2000 Feb; 6(1):103-7. PubMed ID: 11208294
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Urinary cross-linked FDP in various renal diseases].
    Inuma H.
    Nihon Jinzo Gakkai Shi; 1994 Feb; 36(2):146-57. PubMed ID: 8139147
    [Abstract] [Full Text] [Related]

  • 13. [Plasminogen activators (t-PA and u-PA) and other fibrinolysis parameters in patients with atherosclerosis obliterans and diabetic macroangiopathy].
    Zalewska-Rydzkowska D, Rość D, Ponikowska I, Michalski A, Graczykowska-Koczorowska A, Rydzkowski M.
    Pol Merkur Lekarski; 2001 Nov; 11(65):414-7. PubMed ID: 11852811
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Expression of glomerular plasminogen activator inhibitor type 1 in glomerulonephritis.
    Hamano K, Iwano M, Akai Y, Sato H, Kubo A, Nishitani Y, Uyama H, Yoshida Y, Miyazaki M, Shiiki H, Kohno S, Dohi K.
    Am J Kidney Dis; 2002 Apr; 39(4):695-705. PubMed ID: 11920334
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A, Ruusuvaara L.
    Thromb Haemost; 1988 Dec 22; 60(3):361-4. PubMed ID: 3149043
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.